VectivBio Holding AG (VECT) Income Annual - Discounting Cash Flows
VECT
VectivBio Holding AG
VECT (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing 2022-12-31 2023-04-19 2022-04-07 2020-12-31 2019-12-31
Revenue 27.34 27.34 0 0 0
Cost of Revenue 0 0 0 0 0
Gross Profit 27.34 27.34 0 0 0
Operating Expenses 107.9 107.9 86.72 57.26 24.32
Research & Development 73.95 73.95 50.18 43.03 15.98
Selling, General and Administrative 33.91 33.91 35.81 14.02 8.23
Other Operating Expenses 0 0 0.729 0.207 0.102
Operating Income -80.52 -80.52 -86.72 -57.26 -24.32
Net Non-Operating Interest -2.49 -2.49 -0.036 -0.553 -0.035
Interest Income 0.676 0.676 0 0.001 0.015
Interest Expense 3.16 3.16 0.036 0.554 0.05
Equity & Other Income/(Expense) -10.62 -10.62 -0.193 -2.13 0.869
Income Before Tax -93.63 -93.63 -86.94 -59.94 -23.48
Income Tax Expense 0.107 0.107 0.064 0.554 0.05
Income Attributable to Non-Controlling Interest 0 0 0 0 0
Net Income -93.73 -93.73 -87.01 -60.5 -23.53
Depreciation and Amortization 0.676 0.676 0.303 -0.293 0.167
EBITDA -79.85 -79.85 -86.41 -57.55 -24.15
Earnings Per Share (EPS) -2.12 -2.12 -3.23 -2.4 -1.01
Diluted Earnings Per Share -2.12 -2.12 -3.23 -2.4 -1.01
Weighted Average Shares Outstanding 44.13 44.13 26.96 25.16 23.35
Diluted Weighted Average Shares Outstanding 44.13 44.13 26.96 25.16 23.35
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program